研究领域：

中药单方、经方及验方防治常见肿瘤、癌前病变及消化内科疾患的物质基础及临床效应机理研究；中药基本理论及临床应用研究；名老中医诊疗经验总结与传承；其他中医内科常见疾病的诊断与临床治疗机理研究等；临床担任中医内科门诊及肿瘤临床诊疗工作，主要从事脾胃肝等常见肿瘤、消化疾患、肺部疾患及女科常见病的中医诊断与治疗；教学方面主要承担《中药学》、《方剂学》、《Chinese Materia Medica》以及《中医英语》等课程的讲授。

学习经历：

1998.09~2003.07 湖北民族学院中医学专业         医学学士；

2003.09~2006.07 湖北中医药大学中医基础理论专业  医学硕士；

2006.09~2009.07 北京中医药大学临床中药学        医学博士。

工作经历：

2009.07~2012.07  pc加拿大预测准确率                 助理教授；

2012.08~至今    pc加拿大预测准确率                  副教授；

2015.02~2016.03  加拿大曼尼托巴大学健康科学院    访问学者。

代表性成果：

1. Zhao XY, Xi SY*, Wang YH*, Xu YXZ, Galia P, Su Y, Cheng Y, Loy GJ, Liu P. Efficacy of Ciji Hua'ai Baosheng formula on the expressions of vascular endothelial growth factor, kinase insert domain-containing receptor and basic fibroblast growth factor in mouse models of H₂₂ hepatocellular carcinoma. J Tradit Chin Med, 2017, 37(1): 88-95.

2. Xi SY*, Peng Y, Minuk GY, Shi MM, Fu BQ, Yang JQ, Li Q, Gong YW, Yue LF, Li LL, Guo JH, Peng Y, Wang YH. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H₂₂ hepatocellular carcinoma in mice receiving chemotherapy. J Ethnopharmacol, 2016, 190: 1-12.

3. Xi SY*, Shi MM, Jiang XQ, Minuk GY, Cheng Y, Peng Y, Gong YW, Xu YXZ, Wang XR, Yang JQ, Yue LF, Wang YH. The effects of Tao-Hong-Si-Wu on hepatic necroinflammatory activity and fibrosis in a murine model of chronic liver disease. J Ethnopharmacol, 2016, 180: 28-36.

4. Xi SY*, Yue LF, Shi MM, Peng Y, Xu YXZ, Wang XR, Li Q, Kang ZJ, Li HJ, Wang YH. The effects of Taoren-Honghua Herb Pair on pathological microvessel and angiogenesis-associated signaling pathway in mice model of CCl₄-induced chronic liver disease. Evid-based Compl Alt Med, 2016, 2974256: 1-11.

5. Cheng Y, Xi SY*, Wang YH*, Gong YW, Xu YXZ, Shi MM, Loy GJ, Zhao XY. Effects of Ciji Hua’ai Baosheng Formula (CHBF) on apoptosis correlation factors of tumor chemotherapy model mouse with H₂₂ hepatoma carcinoma cells. Afr J Tradit Complement Altern Med, 2015, 12(4): 72-78.

6. Xi SY, Hong RJ, Huang JR, Lu DW, Qian LC, Li PC, Wen L*, Wang YH*. Effects of Ciji Hua’ai Baosheng Granule Formula (CHBGF) on life time, pathology, Peripheral blood cells of tumor chemotherapy model mouse with H₂₂ hepatoma carcinoma cells. Afr J Tradit Complement Altern Med, 2014, 11(4): 94-100.

7. Xi SY, Chuang KH, Fang KM, Lee YM, Chung JG*, Chuang YC*. Effects of Berberine on activity and mRNA expression of N-acetyltransferase in human lung cancer cell line A549. J Tradit Chin Med, 2014, 34(3): 302-308.

8. Xi SY, Qian LC*, Tong HY, Yue LF, Zhao H, Wang DW, Lu  DW, Wang XR. Toxicity and clinical reasonable application of Taoren (Semen Persicae) based on ancient and modern literature research. J Tradit Chin Med, 2013, 33(2): 272-279.

9. Xi SY*, Zhang Q, Liu CY, Xie H, Yue LF, Gao XM. Effects of hydroxy safflower Yellow-A on tumor capillary angiogenesis in transplanted human gastric adenocarcinoma BGC-823 tumors in nude mice. J Tradit Chin Med, 2012, 32(2): 243-248.

10. Xi SY*, Gong YW. Essentials of Chinese Materia Medica and Medical Formulas. Elsevier (Academic Press), 2017, 06.

11. Xi SY*, Yue LF, Qian LC. Essentials for Clinical Practice with Traditional Chinese Medicine. Beijing: People’s Medical Publishing House, 2015, 06.

主持过的重要课题：

1. 福建省自然科学基金面上项目：慈济化癌保生II号方调整肝癌化疗后失稳内环境的作用及机理研究，2018.01-2020.12.

2. 国家自然科学基金青年基金：基于已知吸收成分调控病理血管生成-肝纤维化并与母方桃红四物汤疗效的比较，2013.01-2015.12.

3. 福建省自然科学基金面上项目：红花组分HSYA与复方桃红汤对肝纤维化病理血管负效应及PI3K-AKT信号机制的影响，2014.01-2016.12.

已申请的专利：

1. 王彦晖,奚胜艳. 一种降低肿瘤患者复发率中药复方. 2017.08.11, 中国, CN107029188A.

所有论文列表链接：